Showing items 1 - 2 of 2

COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

- Furlong, Eliska, Kotecha, Rishi S., Phillips, Marianne B., Padhye, Bhavna, Dalla-Pozza, Luciano, Alvaro, Frank, Fraser, Christopher J., Nicholls, Wayne, Clark, Julia E., O'Connor, Matthew, Saxon, Benjamin R., Tapp, Heather, Conyers, Rachel, Heath, John, Hunter, SE, Tsui, K, Winstanley, M, Lyver, A, Best, EJ, Wadia, U, Yeoh, D, Blyth, CC, Gottardo, NG, O'Brien, Tracey A., Hansford, Jordan R., Super, Leanne, Downie, Peter, Eisenstat, David D., Haeusler, Gabrielle, McMullan, Brendan

Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia

- Sutton, Rosemary, Shaw, Peter J., Revesz, Tamas, Trahair, Toby N., Dalla-Pozza, Luciano, Marshall, Glenn M., O'Brien, Tracey A., Venn, Nicola C., Law, Tamara, Dissanayake, Anuruddhika, Kilo, Tatjana, Haber, Michelle, Norris, Murray D., Fraser, Chris, Alvaro, Frank

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit